Information between 29th January 2025 - 28th February 2025
Note: This sample does not contain the most recent 2 weeks of information. Up to date samples can only be viewed by Subscribers.
Click here to view Subscription options.
Division Votes |
---|
5 Feb 2025 - Data (Use and Access) Bill [HL] - View Vote Context Lord Mendelsohn voted No - in line with the party majority and against the House One of 128 Labour No votes vs 1 Labour Aye votes Tally: Ayes - 302 Noes - 132 |
5 Feb 2025 - Data (Use and Access) Bill [HL] - View Vote Context Lord Mendelsohn voted No - in line with the party majority and against the House One of 121 Labour No votes vs 4 Labour Aye votes Tally: Ayes - 318 Noes - 130 |
5 Feb 2025 - Institute for Apprenticeships and Technical Education (Transfer of Functions etc) Bill [HL] - View Vote Context Lord Mendelsohn voted No - in line with the party majority and against the House One of 120 Labour No votes vs 1 Labour Aye votes Tally: Ayes - 183 Noes - 127 |
5 Feb 2025 - Water (Special Measures) Bill [HL] - View Vote Context Lord Mendelsohn voted No - in line with the party majority and against the House One of 112 Labour No votes vs 0 Labour Aye votes Tally: Ayes - 123 Noes - 117 |
5 Feb 2025 - Water (Special Measures) Bill [HL] - View Vote Context Lord Mendelsohn voted No - in line with the party majority and against the House One of 111 Labour No votes vs 0 Labour Aye votes Tally: Ayes - 168 Noes - 112 |
25 Feb 2025 - National Insurance Contributions (Secondary Class 1 Contributions) Bill - View Vote Context Lord Mendelsohn voted No - in line with the party majority and against the House One of 143 Labour No votes vs 1 Labour Aye votes Tally: Ayes - 189 Noes - 151 |
25 Feb 2025 - National Insurance Contributions (Secondary Class 1 Contributions) Bill - View Vote Context Lord Mendelsohn voted No - in line with the party majority and against the House One of 143 Labour No votes vs 0 Labour Aye votes Tally: Ayes - 199 Noes - 149 |
25 Feb 2025 - National Insurance Contributions (Secondary Class 1 Contributions) Bill - View Vote Context Lord Mendelsohn voted No - in line with the party majority and against the House One of 145 Labour No votes vs 1 Labour Aye votes Tally: Ayes - 235 Noes - 152 |
26 Feb 2025 - Product Regulation and Metrology Bill [HL] - View Vote Context Lord Mendelsohn voted No - in line with the party majority and in line with the House One of 142 Labour No votes vs 1 Labour Aye votes Tally: Ayes - 189 Noes - 232 |
25 Feb 2025 - National Insurance Contributions (Secondary Class 1 Contributions) Bill - View Vote Context Lord Mendelsohn voted No - in line with the party majority and against the House One of 139 Labour No votes vs 0 Labour Aye votes Tally: Ayes - 182 Noes - 144 |
25 Feb 2025 - National Insurance Contributions (Secondary Class 1 Contributions) Bill - View Vote Context Lord Mendelsohn voted No - in line with the party majority and in line with the House One of 153 Labour No votes vs 0 Labour Aye votes Tally: Ayes - 97 Noes - 169 |
25 Feb 2025 - National Insurance Contributions (Secondary Class 1 Contributions) Bill - View Vote Context Lord Mendelsohn voted No - in line with the party majority and against the House One of 159 Labour No votes vs 1 Labour Aye votes Tally: Ayes - 305 Noes - 175 |
25 Feb 2025 - National Insurance Contributions (Secondary Class 1 Contributions) Bill - View Vote Context Lord Mendelsohn voted No - in line with the party majority and against the House One of 143 Labour No votes vs 1 Labour Aye votes Tally: Ayes - 235 Noes - 149 |
25 Feb 2025 - National Insurance Contributions (Secondary Class 1 Contributions) Bill - View Vote Context Lord Mendelsohn voted No - in line with the party majority and in line with the House One of 145 Labour No votes vs 0 Labour Aye votes Tally: Ayes - 77 Noes - 153 |
Written Answers |
---|
Cancer: Drugs
Asked by: Lord Mendelsohn (Labour - Life peer) Wednesday 29th January 2025 Question to the Department of Health and Social Care: To ask His Majesty's Government what steps they are taking steps to prioritise the use of cost and clinically effective cancer medicines that result in fewer patient visits to hospital. Answered by Baroness Merron - Parliamentary Under-Secretary (Department of Health and Social Care) The National Institute for Health and Care Excellence (NICE) makes recommendations on whether all new medicines, including cancer medicines, should be routinely funded by the National Health Service based on an assessment of their costs and benefits. The NHS in England is legally required to fund medicines recommended by the NICE, and cancer medicines are eligible for funding from the Cancer Drugs Fund from the point of positive draft NICE guidance. In determining whether a medicine represents a clinically and cost effective use of NHS resources, the NICE takes into account the impact of new medicines on health outcomes and the health and care system, including where costs may be incurred and where savings may be realised. |
Blood Cancer: Medical Treatments
Asked by: Lord Mendelsohn (Labour - Life peer) Thursday 30th January 2025 Question to the Department of Health and Social Care: To ask His Majesty's Government what assessment they have made of infusion capacity within the NHS for blood cancer treatments. Answered by Baroness Merron - Parliamentary Under-Secretary (Department of Health and Social Care) No assessment has been made of infusion capacity within the National Health Service for blood cancer treatments. However, it is a priority for the Government to support the NHS to diagnose and treat cancer, including blood cancer, as early and quickly as possible. The Department is committing to this by delivering an extra 40,000 operations, scans, and appointments each week, to support increased capacity. |
Blood Cancer: Medical Treatments
Asked by: Lord Mendelsohn (Labour - Life peer) Thursday 30th January 2025 Question to the Department of Health and Social Care: To ask His Majesty's Government what steps they are taking to ensure haemato-oncology services have the capacity to plan and adopt new innovations in the treatment of blood cancer. Answered by Baroness Merron - Parliamentary Under-Secretary (Department of Health and Social Care) The National Disease Registration Service, through the National Cancer Registration and Analysis Services, collects information on how many people in England have blood cancer, labelled as haematological neoplasms. This data supports service provision and commissioning in the National Health Service, clinical audits, and public health and epidemiological research, all of which contributes to improved outcomes for cancer patients, including blood cancer patients. The Department is committed to implementing the recommendations of Lord O'Shaughnessy’s review into commercial clinical trials, making sure that the United Kingdom leads the world in clinical trials, and ensuring that innovative, lifesaving treatments are accessible to NHS patients, including those with blood cancer. |
Genocide: Rwanda
Asked by: Lord Mendelsohn (Labour - Life peer) Monday 10th February 2025 Question to the Home Office: To ask His Majesty's Government what information they have about the five Rwandan genocide suspects named in an extradition judgment and currently living in the UK. Answered by Lord Hanson of Flint - Minister of State (Home Office) I refer Lord Mendelsohn to UIN 249920 and UIN HL787, where similar questions were posed. The Metropolitan Police Service (MPS) War Crimes Unit is a dedicated specialist unit which investigates and prosecutes people living in the UK suspected of committing war crimes and crimes against humanity in line with universal jurisdiction and the CPS Counter Terrorism Division has the responsibility for prosecuting such crimes. Criminal investigations are an operational matter for law-enforcement agencies, and it would be inappropriate for me to comment any further. I would invite Lord Mendelsohn to consider referring the second part of the question to the Attorney General and the Metropolitan Police for a response. |
War Crimes: Rwanda
Asked by: Lord Mendelsohn (Labour - Life peer) Monday 10th February 2025 Question to the Home Office: To ask His Majesty's Government what explanations they have received from the police regarding the length of time taken to investigate the cases of the five suspected Rwandan war criminals currently living in the UK following the judgment in Government of Rwanda v Nteziryayo & Others [2017] EWHC 1912 (Admin), and what assessment they have made of the effectiveness of those police investigations. Answered by Lord Hanson of Flint - Minister of State (Home Office) I refer Lord Mendelsohn to UIN 249920 and UIN HL787, where similar questions were posed. The Metropolitan Police Service (MPS) War Crimes Unit is a dedicated specialist unit which investigates and prosecutes people living in the UK suspected of committing war crimes and crimes against humanity in line with universal jurisdiction and the CPS Counter Terrorism Division has the responsibility for prosecuting such crimes. Criminal investigations are an operational matter for law-enforcement agencies, and it would be inappropriate for me to comment any further. I would invite Lord Mendelsohn to consider referring the second part of the question to the Attorney General and the Metropolitan Police for a response. |
Genocide: Rwanda
Asked by: Lord Mendelsohn (Labour - Life peer) Monday 10th February 2025 Question to the Home Office: To ask His Majesty's Government on what date the Attorney General last received a briefing from the Metropolitan Police regarding the five Rwandan genocide suspects named in an extradition judgement and currently living in the UK. Answered by Lord Hanson of Flint - Minister of State (Home Office) We would invite you to consider referring this question to the Attorney General and the Metropolitan Police for a response. |
Parliamentary Debates |
---|
Introduction: Lord Raval
1 speech (1 words) Tuesday 4th February 2025 - Lords Chamber Mentions: 1: None , of Hertsmere in the County of Hertfordshire, was introduced and took the oath, supported by Lord Mendelsohn - Link to Speech |